189 related articles for article (PubMed ID: 24130255)
1. Coaching intervention as a strategy for minority recruitment to cancer clinical trials.
Fracasso PM; Goodner SA; Creekmore AN; Morgan HP; Foster DM; Hardmon AA; Engel SJ; Springer BC; Mathews KJ; Fisher EB; Walker MS
J Oncol Pract; 2013 Nov; 9(6):294-9. PubMed ID: 24130255
[TBL] [Abstract][Full Text] [Related]
2. Race, medical researcher distrust, perceived harm, and willingness to participate in cardiovascular prevention trials.
Braunstein JB; Sherber NS; Schulman SP; Ding EL; Powe NR
Medicine (Baltimore); 2008 Jan; 87(1):1-9. PubMed ID: 18204365
[TBL] [Abstract][Full Text] [Related]
3. The influence of race on the attitudes of radiation oncology patients towards clinical trial enrollment.
Wood CG; Wei SJ; Hampshire MK; Devine PA; Metz JM
Am J Clin Oncol; 2006 Dec; 29(6):593-9. PubMed ID: 17148997
[TBL] [Abstract][Full Text] [Related]
4. Involving South Asian patients in clinical trials.
Hussain-Gambles M; Leese B; Atkin K; Brown J; Mason S; Tovey P
Health Technol Assess; 2004 Oct; 8(42):iii, 1-109. PubMed ID: 15488164
[TBL] [Abstract][Full Text] [Related]
5. Perceptions of participation in a phase I, II, or III clinical trial among African American patients with cancer: what do refusers say?
Brown RF; Cadet DL; Houlihan RH; Thomson MD; Pratt EC; Sullivan A; Siminoff LA
J Oncol Pract; 2013 Nov; 9(6):287-93. PubMed ID: 24130251
[TBL] [Abstract][Full Text] [Related]
6. The role of health literacy on African American and Hispanic/Latino perspectives on cancer clinical trials.
Evans KR; Lewis MJ; Hudson SV
J Cancer Educ; 2012 Jun; 27(2):299-305. PubMed ID: 22203466
[TBL] [Abstract][Full Text] [Related]
7. Minority Recruitment Trends in Phase III Prostate Cancer Clinical Trials (2003 to 2014): Progress and Critical Areas for Improvement.
Balakrishnan AS; Palmer NR; Fergus KB; Gaither TW; Baradaran N; Ndoye M; Breyer BN
J Urol; 2019 Feb; 201(2):259-267. PubMed ID: 30218761
[TBL] [Abstract][Full Text] [Related]
8. Factors Associated With Racial/Ethnic Group-Based Medical Mistrust and Perspectives on COVID-19 Vaccine Trial Participation and Vaccine Uptake in the US.
Thompson HS; Manning M; Mitchell J; Kim S; Harper FWK; Cresswell S; Johns K; Pal S; Dowe B; Tariq M; Sayed N; Saigh LM; Rutledge L; Lipscomb C; Lilly JY; Gustine H; Sanders A; Landry M; Marks B
JAMA Netw Open; 2021 May; 4(5):e2111629. PubMed ID: 34042990
[TBL] [Abstract][Full Text] [Related]
9. Participation in cancer clinical trials: race-, sex-, and age-based disparities.
Murthy VH; Krumholz HM; Gross CP
JAMA; 2004 Jun; 291(22):2720-6. PubMed ID: 15187053
[TBL] [Abstract][Full Text] [Related]
10. Primary care physicians' attitudes and beliefs about cancer clinical trials.
Bylund CL; Weiss ES; Michaels M; Patel S; D'Agostino TA; Peterson EB; Binz-Scharf MC; Blakeney N; McKee MD
Clin Trials; 2017 Oct; 14(5):518-525. PubMed ID: 28693389
[TBL] [Abstract][Full Text] [Related]
11. An educational video to increase clinical trials enrollment among breast cancer patients.
Du W; Mood D; Gadgeel S; Simon MS
Breast Cancer Res Treat; 2009 Sep; 117(2):339-47. PubMed ID: 19152024
[TBL] [Abstract][Full Text] [Related]
12. Exploring Willingness to Participate in Clinical Trials by Ethnicity.
Pariera KL; Murphy ST; Meng J; McLaughlin ML
J Racial Ethn Health Disparities; 2017 Aug; 4(4):763-769. PubMed ID: 27604379
[TBL] [Abstract][Full Text] [Related]
13. Recruitment and retention of low-income minority women in a behavioral intervention to reduce smoking, depression, and intimate partner violence during pregnancy.
El-Khorazaty MN; Johnson AA; Kiely M; El-Mohandes AA; Subramanian S; Laryea HA; Murray KB; Thornberry JS; Joseph JG
BMC Public Health; 2007 Sep; 7():233. PubMed ID: 17822526
[TBL] [Abstract][Full Text] [Related]
14. Discordant attitudes and beliefs about cancer clinical trial participation between physicians, research staff, and cancer patients.
Hillyer GC; Beauchemin M; Hershman DL; Kelsen M; Brogan FL; Sandoval R; Schmitt KM; Reyes A; Terry MB; Lassman AB; Schwartz GK
Clin Trials; 2020 Apr; 17(2):184-194. PubMed ID: 32009456
[TBL] [Abstract][Full Text] [Related]
15. Partnering around cancer clinical trials (PACCT): study protocol for a randomized trial of a patient and physician communication intervention to increase minority accrual to prostate cancer clinical trials.
Eggly S; Hamel LM; Heath E; Manning MA; Albrecht TL; Barton E; Wojda M; Foster T; Carducci M; Lansey D; Wang T; Abdallah R; Abrahamian N; Kim S; Senft N; Penner LA
BMC Cancer; 2017 Dec; 17(1):807. PubMed ID: 29197371
[TBL] [Abstract][Full Text] [Related]
16. Willingness to participate in clinical trials among African Americans and whites previously exposed to clinical research.
Durant RW; Legedza AT; Marcantonio ER; Freeman MB; Landon BE
J Cult Divers; 2011; 18(1):8-19. PubMed ID: 21526582
[TBL] [Abstract][Full Text] [Related]
17. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
18. Are ethnic and racial minority women less likely to participate in clinical trials?
Patel SN; Staples JN; Garcia C; Chatfield L; Ferriss JS; Duska L
Gynecol Oncol; 2020 May; 157(2):323-328. PubMed ID: 32253046
[TBL] [Abstract][Full Text] [Related]
19. Do Current Lung Cancer Clinical Trials Represent All Patient Populations Including Minorities?
Nemala A; Ullah A; Yacur M; Karim NA
Clin Lung Cancer; 2023 Nov; 24(7):573-580. PubMed ID: 37574437
[TBL] [Abstract][Full Text] [Related]
20. Clinical trial participation among ethnic/racial minority and majority patients with advanced cancer: what factors most influence enrollment?
Jimenez R; Zhang B; Joffe S; Nilsson M; Rivera L; Mutchler J; Lathan C; Paulk ME; Prigerson HG
J Palliat Med; 2013 Mar; 16(3):256-62. PubMed ID: 23384245
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
